Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02371330 · ClinicalTrials.gov registry record
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia Study
A clinical trial, sponsored by Karolinska Institutet.
- Completed
- Registry status
- 76
- Enrollment target
NCT02371330 is a clinical trial that has completed, run by Karolinska Institutet. The registered enrollment target is 76 participants.
The verdict
NCT02371330 has completed, sponsored by Karolinska Institutet.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
Study Summary
This is a prospective longitudinal study that evaluates Platelet Function Analyzer-100 (PFA-100) CT-ADPs (closure time-ADP) and incidence of bleeding using the Neonatal Bleeding Assessment Tool - Neo-BAT in preterm neonates \<32 weeks gestational age or with a birth weight \<1500 grams and with different degrees of thrombocytopenia. The investigators hypothesized that PFA-100 CT-ADP, a global in vitro test of primary hemostasis, will be a better predictor of clinical bleeding in neonates than platelet count alone. A bleeding risk assessment marker could help physicians more accurately determine the risk/benefit ratio of platelet transfusions, guiding platelet transfusion decisions in neonates with thrombocytopenia.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2015-04 |
| Est. Completion | 2017-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02371330
The ClinicalTrials.gov registry entry for NCT02371330 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Karolinska Institutet, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02371330 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02371330 about?
NCT02371330 is a clinical study titled "The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia Study". This is a prospective longitudinal study that evaluates Platelet Function Analyzer-100 (PFA-100) CT-ADPs (closure time-ADP) and incidence of bleeding using the Neonatal Bleeding Assessment Tool - Neo-BAT in preterm neonates \<32 weeks gestational age or with a birth weight \<1500 grams and with diff...
What is the current status of trial NCT02371330?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2015-04. Estimated completion is 2017-09.
Who is sponsoring clinical trial NCT02371330?
This trial is sponsored by Karolinska Institutet, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.